Management of Lung Cancer

Overview

Journal Qual Health Care

Specialty Health Services

Date 1998 Aug 5

PMID 10185145

Authors

A Melville

A Eastwood

Affiliations

Soon will be listed here.

References

Higginson I, McCarthy M . Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?. J R Soc Med. 1989; 82(5):264-7. PMC: 1292128. DOI: 10.1177/014107688908200507. View

McCorkle R, Benoliel J, Donaldson G, Georgiadou F, Moinpour C, Goodell B . A randomized clinical trial of home nursing care for lung cancer patients. Cancer. 1989; 64(6):1375-82. DOI: 10.1002/1097-0142(19890915)64:6<1375::aid-cncr2820640634>3.0.co;2-6. View

Goddard M . The role of economics in the evaluation of hospice care. Health Policy. 1989; 13(1):19-34. DOI: 10.1016/0168-8510(89)90108-5. View

Spiro S, Souhami R . Duration of chemotherapy in small cell lung cancer. Thorax. 1990; 45(1):1-2. PMC: 475628. DOI: 10.1136/thx.45.1.1. View

Geddes D, Dones L, Hill E, Law K, Harper P, Spiro S . Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer. 1990; 26(4):484-92. DOI: 10.1016/0277-5379(90)90022-l. View

Jaakkimainen L, Goodwin P, Pater J, Warde P, Murray N, Rapp E . Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer. J Clin Oncol. 1990; 8(8):1301-9. DOI: 10.1200/JCO.1990.8.8.1301. View

Tsang V, Fernando H, Goldstraw P . Pleuroperitoneal shunt for recurrent malignant pleural effusions. Thorax. 1990; 45(5):369-72. PMC: 462476. DOI: 10.1136/thx.45.5.369. View

Brundage M, Davidson J, Mackillop W . Trading treatment toxicity for survival in locally advanced non-small cell lung cancer. J Clin Oncol. 1997; 15(1):330-40. DOI: 10.1200/JCO.1997.15.1.330. View

Evans W, Le Chevalier T . The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer. Eur J Cancer. 1996; 32A(13):2249-55. DOI: 10.1016/s0959-8049(96)00298-5. View

10.

Jantunen I, Kataja V, Muhonen T . An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer. 1997; 33(1):66-74. DOI: 10.1016/s0959-8049(96)00276-6. View

11.

Strauss G, Gleason R, Sugarbaker D . Screening for lung cancer. Another look; a different view. Chest. 1997; 111(3):754-68. DOI: 10.1378/chest.111.3.754. View

12.

Ream E, Richardson A . The role of information in patients' adaptation to chemotherapy and radiotherapy: a review of the literature. Eur J Cancer Care (Engl). 1996; 5(3):132-8. DOI: 10.1111/j.1365-2354.1996.tb00223.x. View

13.

Souhami R, Spiro S, Rudd R, Ruiz de Elvira M, James L, Gower N . Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy. J Natl Cancer Inst. 1997; 89(8):577-80. DOI: 10.1093/jnci/89.8.577. View

14.

Ornadel D, Duchesne G, Wall P, Ng A, Hetzel M . Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer. 1997; 16(2-3):203-13. DOI: 10.1016/s0169-5002(96)00630-7. View

15.

Hopwood P, Stephens R . Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer. 1995; 71(3):633-6. PMC: 2033650. DOI: 10.1038/bjc.1995.124. View

16.

Arriagada R, Le Chevalier T, Borie F, Riviere A, CHOMY P, Monnet I . Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst. 1995; 87(3):183-90. DOI: 10.1093/jnci/87.3.183. View

17.

Joss R, Alberto P, Hurny C, Bacchi M, Leyvraz S, Thurlimann B . Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide,.... Ann Oncol. 1995; 6(1):41-8. DOI: 10.1093/oxfordjournals.annonc.a059039. View

18.

Dales R, Belanger R, Shamji F, Leech J, Crepeau A, Sachs H . Quality-of-life following thoracotomy for lung cancer. J Clin Epidemiol. 1994; 47(12):1443-9. DOI: 10.1016/0895-4356(94)90088-4. View

19.

Waller D, Morritt G, Forty J . Video-assisted thoracoscopic pleurectomy in the management of malignant pleural effusion. Chest. 1995; 107(5):1454-6. DOI: 10.1378/chest.107.5.1454. View

20.

Peto J, Hodgson J, Matthews F, Jones J . Continuing increase in mesothelioma mortality in Britain. Lancet. 1995; 345(8949):535-9. DOI: 10.1016/s0140-6736(95)90462-x. View